STERIS plc $STE Stock: Benjamin Edwards Inc. Raises Stake

Benjamin Edwards Inc. boosted its stake in STERIS plc (NYSE:STE – Free Report) by 28.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 144,857 shares of the medical equipment provider’s stock after purchasing an additional 31,789 shares during the period. Benjamin Edwards Inc. owned approximately 0.15% of STERIS worth $30,428,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in STE. Western Wealth Management LLC bought a new stake in shares of STERIS during the first quarter valued at approximately $25,000. Compass Financial Management LLC bought a new position in STERIS during the third quarter valued at $25,000. Elevation Wealth Partners LLC grew its holdings in STERIS by 1,130.0% during the 2nd quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 113 shares during the last quarter. Trust Co. of Vermont bought a new stake in STERIS in the second quarter worth about $41,000. Finally, Community Financial Services Group LLC lifted its stake in STERIS by 50.0% in the third quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 72 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Activity at STERIS

In related news, VP Julia Madsen sold 2,046 shares of STERIS stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $260.00, for a total value of $531,960.00. Following the completion of the sale, the vice president owned 10,211 shares in the company, valued at approximately $2,654,860. This trade represents a 16.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Karen L. Burton sold 5,880 shares of the business’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $255.62, for a total value of $1,503,045.60. Following the completion of the sale, the chief financial officer owned 12,956 shares in the company, valued at $3,311,812.72. This represents a 31.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 12,819 shares of company stock worth $3,274,011. Insiders own 1.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group upgraded shares of STERIS from a “hold” rating to a “buy” rating and lifted their price objective for the company from $232.00 to $305.00 in a report on Friday, November 13th. Weiss Ratings raised shares of STERIS from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, November 9th. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 14th. Morgan Stanley raised shares of STERIS from an “overweight” rating to a “buy” rating in a research note on Friday, November 13th. Finally, Piper Sandler restated an “overweight” rating and set a $275.00 target price (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, STERIS currently has an average rating of “Moderate Buy” and an average target price of $283.50.

View Our Latest Stock Report on STERIS

STERIS Price Performance

STERIS stock opened at $255.66 on Friday. The stock has a market capitalization of $24.83 billion, a P/E ratio of 30.33 and a beta of 0.86. The company’s fifty day moving average price is $227.43 and its 200 day moving average price is $224.49. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.44 and a current ratio of 2.05. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44.

STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 EPS for the quarter, topping the consensus estimate of $2.68 by $0.26. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the business earned $2.47 earnings per share. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. As a group, equities research analysts anticipate that STERIS plc will post 11.46 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Tuesday, November 17th will be issued a $0.69 dividend. The ex-dividend date is Tuesday, November 17th. This represents a $2.76 dividend on an annualized basis and a yield of 1.1%. STERIS’s dividend payout ratio is currently 32.74%.

STERIS Company Profile

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

See Also

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.